Randomized_dose-searching_phase_ILE/II_trials_of_fractionation_in_radiation_therapy_for_cancer._This_article_describes_a_new_design,_phase_ILE/II_dose_searching,_used_in_four_prospective,_randomized,_multicenter_clinical_trials_of_escalating_total_doses_of_hyperfractionated_radiation._This_design_combines_an_experimental_protocol_with_a_statistical_application_of_ranking_and_selection_theory._Its_purpose_was_to_identify_(within_a_certain_margin_of_error)_a_dose_that_achieved_the_highest_rate_of_clinical_response_from_a_set_of_doses_that_were_tolerable_in_terms_of_both_acute_(within_90_days)_and_late_(more_than_90_days)_toxic_effects_(LE)._We_calculated_the_number_of_patients_required_to_reliably_test_toxicity_under_various_assumptions._To_determine_the_maximum_tolerated_total_dose_for_hyperfractionated_radiation,_we_randomly_assigned_patients_with_tumors_that_responded_to_radiation_therapy_in_a_dose-dependent_manner_from_four_body_sites_(lung,_upper_respiratory_and_digestive_tract,_bladder,_and_brain)_to_one_of_three_regimens_receiving_total_doses_(D1,_D2,_or_D3)_differing_by_increments_of_4.8_Gy._All_patients_received_two_fractions_of_1.2_Gy_each_(separated_by_4-6_hours)_daily_5_days_a_week._The_lowest_total_dose_was_set_at_the_level_considered_tolerable_with_standard_once-a-day_radiation_therapy._We_tested_tumor_responses_and_late_toxic_effects_of_higher_doses_by_assigning_patients_to_these_three_regimens_until_acute_effects_and_early_estimates_of_late_effects_were_found_to_be_acceptable_for_the_highest_dose_D3;_thereafter,_regimen_D1_was_closed,_and_additional_patients_were_assigned_to_D2,_D3,_and_D4_(an_escalated_total_dose_greater_than_D3_by_an_increment_of_4.8_Gy)._The_assignment_of_patients_was_performed_in_a_weighted_manner_(1:1:2),_so_that_greater_numbers_were_assigned_to_the_highest_dose_regimen_(whether_D3_or_D4)_to_allow_rapid_evaluation_of_the_feasibility_of_the_highest_dose.